Insulin aspart, recombinant Subcutaneous and Pentamycetin Ophthalmic Solution 0.5%
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Pentamycetin Ophthalmic Solution 0.5% and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: chloramphenicol ophthalmic
Brand name:
Synonyms: Chloramphenicol (Ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Pentasa
- Insulin aspart, recombinant Subcutaneous-Pentasa Rectal
- Insulin aspart, recombinant Subcutaneous-Pentazocine
- Insulin aspart, recombinant Subcutaneous-Pentazocine Acetaminophen
- Insulin aspart, recombinant Subcutaneous-Pentazocine and Naloxone
- Insulin aspart, recombinant Subcutaneous-Pentazocine Hydrochloride
- Pentamycetin Ophthalmic Solution 0.5%-Insulin degludec
- Pentamycetin Ophthalmic Solution 0.5%-Insulin Degludec (U-100) Prefilled Pens
- Pentamycetin Ophthalmic Solution 0.5%-Insulin Degludec (U-100) Vials
- Pentamycetin Ophthalmic Solution 0.5%-Insulin Degludec (U-200) Prefilled Pens
- Pentamycetin Ophthalmic Solution 0.5%-Insulin degludec and liraglutide
- Pentamycetin Ophthalmic Solution 0.5%-Insulin degludec and liraglutide Subcutaneous